A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey

被引:5
作者
Pathak, Anuj Kumar [1 ]
Kumar, Manish [1 ]
Dokania, Shambhu [2 ]
Mohan, Lalit [1 ]
Dikshit, Harihar [1 ]
机构
[1] IGIMS, Dept Pharmacol, Patna 14, Bihar, India
[2] IGIMS, ADR Monitoring Ctr, Pharmacovigilance Programme India PvPI, Patna, Bihar, India
关键词
ADR reporting; Drugs; Pharmacovigilance; Pharmacovigilance program of India;
D O I
10.7860/JCDR/2016/18826.8284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pharmacovigilance (PV) is related to detection, assessment, understanding and prevention of Adverse Drug Reactions (ADRs) which are incurred when drug is made available in the market and used in different physiological conditions. In many countries, ADRs ranks among the top ten leading cause of morbidity and mortality. There is a lack of formal culture for monitoring and reporting of ADRs in India, with ADR reporting rate being only 1% as compared to 5% in world. This type of academic detailing activity helps to create awareness of ADR reporting in the institutions. Aim: This study was planned to evaluate and analyse the incidence and patterns of ADRs in various inpatient and outpatient departments of hospital. Materials and Methods: This was an observational, retrospective and record based study conducted by analysing the spontaneous ADR forms, collected over a period of 12 months (September 2014 to August 2015) at Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India. Results: During the period of one year, 292 ADR forms were collected from 4,34,965 patients attending OPD and inpatients of the hospital. Incidence of ADR was 0.67 per thousand patients and average of around 24 ADR collected per month. Male: Female ratio was 1.30. Adolescent (16-30 yr) was the most common age group affected. Department of Skin and VD reported the maximum number of ADRs (33.22%), followed by the Departments of Oncology (18.84%). Antibiotics were the most common drug implicated followed by anticancer drugs. Conclusion: ADR reporting is an ongoing and continuous process. Studies from the institute helps to identify and rectify the problems related to ADR reporting. Pitfalls can be addressed by creating awareness among physicians and the patients to achieve finally the goal of Pharmacovigilant India.
引用
收藏
页码:FC1 / FC4
页数:4
相关论文
共 50 条
[21]   Adverse drug reactions' reporting in a Mexican hospital [J].
Aidee Valdez-Ramirez, Lourdes ;
Serrano-Medina, Aracely ;
Manuel Cornejo-Bravo, Jose .
INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2020, 28 (06) :660-662
[22]   Distinguishing adverse drug reactions, the noxious effects of medicines at a tertiary care hospital [J].
Nia, Siavash Shahbazi ;
Modaresahmadi, Shadan ;
Zaei, Armin Eisa .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2018, 8 (02) :69-73
[23]   Improving the Reporting of Adverse Drug Reactions in the Hospital Setting [J].
Pushkin, Richard ;
Frassetto, Lynda ;
Tsourounis, Candy ;
Segal, Eleanor S. ;
Kim, Stephanie .
POSTGRADUATE MEDICINE, 2010, 122 (06) :154-164
[24]   DEVELOPMENT OF ADVERSE DRUG REACTION REPORTING CULTURE IN SECOND PROFESSIONAL MEDICAL UNDERGRADUATES AT TERTIARY CARE TEACHING HOSPITAL: A HEALTH IMPERATIVE [J].
Parihar, Deepak ;
Kothiyal, Gitanjali ;
Raina, Rangeel Singh ;
Singh, Priyanka ;
Thakur, Heenopama ;
Chaturvedi, Aditi ;
Dutt, Hemant Kumar .
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (26) :7245-7252
[25]   Probing the in-depth analysis of Serious Adverse Drug Reactions in a tertiary care hospital of Central India [J].
Singh, Preeti ;
Verma, Shekhar ;
Vaishnav, Yogesh ;
Joshi, Usha ;
Agrawal, Manju .
EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2025, 17
[26]   A STUDY TO ASSESS KNOWLEDGE, ATTITUDE AND PRACTICE OF ADVERSE DRUG REACTION REPORTING AMONG PHYSICIANS IN A TERTIARY CARE HOSPITAL [J].
Adhikary, Jyotirmoy ;
Bhandare, Basavaraj ;
Adarsh, E. ;
Satyanarayana, V .
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (09) :1027-1034
[27]   Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands [J].
Dittrich, Anne T. M. ;
Draaisma, Jos M. T. ;
van Puijenbroek, Eugene P. ;
te Loo, D. Maroeska W. M. .
PEDIATRIC DRUGS, 2020, 22 (04) :425-432
[28]   Pediatric Pharmacovigilance: Enhancing Adverse Drug Reaction Reporting in a Tertiary Care Children’s Hospital [J].
Jennifer L. Goldman ;
Amanda Sullins ;
Tracy Sandritter ;
J. Steven Leeder ;
Jennifer Lowry .
Therapeutic Innovation & Regulatory Science, 2013, 47 :566-571
[29]   Pediatric Pharmacovigilance: Enhancing Adverse Drug Reaction Reporting in a Tertiary Care Children's Hospital [J].
Goldman, Jennifer L. ;
Sullins, Amanda ;
Sandritter, Tracy ;
Leeder, J. Steven ;
Lowry, Jennifer .
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (05) :566-571
[30]   Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India [J].
Mittal, Niti ;
Gupta, Mahesh ;
Singla, Mohit .
CUTANEOUS AND OCULAR TOXICOLOGY, 2014, 33 (04) :289-293